Antithrombin plus alpha-1 protease inhibitor does not affect pulmonary inflammation and coagulation in a 'double-hit' lung injury model

Authors :: Matthias Adrie Willem Maas
Nicole P. Juffermans
Jenny Juschten
Armand Ro Jo Girbes
Marcus J. Schultz
Pieter R. Tuinman
Sarah Anna Ingelse
Intensive care medicine
AII - Inflammatory diseases
ACS - Diabetes & metabolism
ACS - Pulmonary hypertension & thrombosis
Source :: Juschten, J, Ingelse, S A, Maas, M A W, Girbes, A R J, Juffermans, N P, Schultz, M J & Tuinman, P R 2018, ' Antithrombin plus alpha-1 protease inhibitor does not affect pulmonary inflammation and coagulation in a 'double-hit' lung injury model ', European Respiratory Journal, vol. 52 . https://doi.org/10.1183/13993003.congress-2018.PA2312, European Respiratory Journal, 52. European Respiratory Society
Publication Year :: 2018

Subjects :: Double hit
Coagulation
business.industry
Pulmonary inflammation
Antithrombin
Medicine
Alpha (ethology)
Lung injury
Pharmacology
business
Protease inhibitor (biology)
medicine.drug

Language :: English
ISSN :: 09031936
Database :: OpenAIRE
Journal :: Juschten, J, Ingelse, S A, Maas, M A W, Girbes, A R J, Juffermans, N P, Schultz, M J & Tuinman, P R 2018, ' Antithrombin plus alpha-1 protease inhibitor does not affect pulmonary inflammation and coagulation in a 'double-hit' lung injury model ', European Respiratory Journal, vol. 52 . https://doi.org/10.1183/13993003.congress-2018.PA2312, European Respiratory Journal, 52. European Respiratory Society
Accession number :: edsair.doi.dedup.....9819498bd3be3b9ad99ace99dc313acd
Full Text :: https://doi.org/10.1183/13993003.congress-2018.PA2312

Full Text Access

Tools